Condition
NRF2 Mutation
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Related Conditions
Often studied with 5 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
100.0%
1 terminated out of 1 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
Trial Status
Terminated1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Active Sponsors
- Calithera Biosciences, Inc1
Top Investigators
Calithera Biosciences, Inc
Related Conditions
- Nonsmall Cell Lung Cancer1
- Nonsquamous Nonsmallcell Lung Cancer1
- Nfe2l2 Gene Mutation1
- Keap1 Gene Mutation1
- Nonsquamous Nonsmall Cell Neoplasm Of Lung1